SCHEMBL258790

SCHEMBL258790

O=C(O)C1CCCCN1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACE P12821 7/20 0.50
REN P00797 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1950731 1.00 ACE (0.50) ACEREN
SCHEMBL6478173 1.00 ACE (0.50) ACEREN
SCHEMBL3791081 0.98 ACE (0.49) ACE
SCHEMBL21874335 0.98 ACE (0.49) ACE
SCHEMBL27957044 0.98 ACE (0.49) ACE
SCHEMBL750903 0.93 ACE (0.56) ACEREN
SCHEMBL1543546 0.93 ACE (0.56) ACEREN
SCHEMBL187408 0.93 ACE (0.56) ACEREN
Bromide SCHEMBL6544002 0.91 ACE (0.55) ACEREN
Ammonia Solution, Strong SCHEMBL29036066 0.91 ACE (0.55) ACEREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120059154-A In C4Method for producing polybutylene succinate polyester by taking unsaturated binary oxygen-containing compound as raw material 上海师范大学 2025-05-30 CN claimed
CN-118183834-A Preparation method of defect-state nano oxide and application of defect-state nano oxide in polyether ester synthesis 中国科学院大连化学物理研究所 2024-06-14 CN claimed
CN-118184982-A Polyester and synthetic method thereof 中国科学院大连化学物理研究所 2024-06-14 CN claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
CN-1168443-C Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors ��̩��˹ҩ��ɷ����޹�˾ 2004-09-29 CN claimed
CN-1239434-A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors VERTED PHARMACEUTICALS INC (US) 1999-12-22 CN claimed
EP-0300462-A2 Heterocyclic peroxycarboxylic acids AUSIMONT S.p.A. (IT) 1989-01-25 EP claimed
JP-6172309-A None JP disclosed
JP-8198853-A None JP disclosed
US-20260014265-A1 TRIPLE-PAYLOAD ANTIBODY-DRUG CONJUGATES (ADCs) ARARIS BIOTECH AG (CH) 2026-01-15 US disclosed
CN-120059154-A In C4Method for producing polybutylene succinate polyester by taking unsaturated binary oxygen-containing compound as raw material 上海师范大学 2025-05-30 CN disclosed
EP-4217356-B1 CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2025-05-14 EP disclosed
CN-119868377-A Combination therapy for the treatment of cancer 阿斯利康(瑞典)有限公司 2025-04-25 CN disclosed
WO-1990008157-A1 PLATINUM PHARMACEUTICAL AGENTS GEORGETOWN UNIVERSITY (US) 1990-07-26 WO disclosed
EP-0360390-A1 Spirolactam derivatives GLAXO GROUP LIMITED (GB) 1990-03-28 EP disclosed
EP-0138795-B1 HERBICIDAL METHOD AND COMPOSITIONS CONTAINING 3,5-DICARBOXYLIC ACID ESTERS OF 2,6-BIS-(FLUOROALKYL) TETRAHYDROPYRANS AND PIPERIDINES MONSANTO COMPANY (US) 1989-10-18 EP disclosed
US-4816062-A PREEMERGENCE HERBICIDES MONSANTO COMPANY (US) 1989-03-28 US disclosed
EP-0300462-A2 Heterocyclic peroxycarboxylic acids AUSIMONT S.p.A. (IT) 1989-01-25 EP disclosed
US-4618679-A PREEMERGENCE HERBICIDES MONSANTO COMPANY (US) 1986-10-21 US disclosed
EP-0138795-A1 Herbicidal method and compositions containing 3,5-dicarboxylic acid esters of 2,6-bis-(fluoroalkyl) tetrahydropyrans and piperidines MONSANTO COMPANY (US) 1985-04-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014265-A1 TRIPLE-PAYLOAD ANTIBODY-DRUG CONJUGATES (ADCs) TOP2A, TOP1, TOP2B ACE 3946/4885REN 4765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.